Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective
The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, is wreaking havoc around the world. Considering that extracellular vesicles (EVs) released from SARS-CoV-2 infected cells might play a role in a viremic phase contributing to disease progression and that standard metho...
Main Authors: | Yury O. Nunez Lopez, Anna Casu, Richard E. Pratley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.617042/full |
Similar Items
-
Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles
by: Maëva Durcin, et al.
Published: (2017-12-01) -
Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin
by: Rosanne E. Veerman, et al.
Published: (2021-07-01) -
Routes and mechanisms of extracellular vesicle uptake
by: Laura Ann Mulcahy, et al.
Published: (2014-08-01) -
Extracellular Vesicles in Skin Wound Healing
by: Deimantė Narauskaitė, et al.
Published: (2021-08-01) -
Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection
by: Carina Conzelmann, et al.
Published: (2020-01-01)